Introduction
Relapsing polychondritis is a rare inflammatory disease that can be difficult to recognize because it may affect several parts of the body at different times. This FAQ explains what the condition is, why it happens, how it is diagnosed, what treatment usually involves, and what people can expect over time. The answers focus on the most common questions patients and families ask, with an emphasis on the underlying cartilage and connective tissue inflammation that defines the disease.
Common Questions About Relapsing Polychondritis
What is relapsing polychondritis? Relapsing polychondritis is an autoimmune or immune-mediated disorder in which the body attacks its own cartilage and related tissues. Cartilage is the firm but flexible tissue found in the ears, nose, windpipe, joints, and other areas. In this condition, repeated episodes of inflammation can damage cartilage over time, which is why the name includes both “relapsing” and “polychondritis.” Relapsing refers to flare-ups, and polychondritis means inflammation of multiple cartilages.
What causes it? The exact cause is not known. Most experts believe relapsing polychondritis develops when the immune system mistakenly targets cartilage proteins, especially those in type II collagen and other structural components of cartilage. Genetic susceptibility may play a role, but the disease is not usually inherited in a simple pattern. In some people, infections, trauma, or other immune triggers may help start the process, though they are not proven direct causes. It is considered rare, and many cases occur without a clear trigger.
What symptoms does it produce? Symptoms depend on which cartilage-containing structures are inflamed. A classic sign is a painful, red, swollen outer ear that often spares the earlobe, because the earlobe has no cartilage. The nose may become tender and swollen, and repeated inflammation can eventually weaken nasal cartilage. When the airway is involved, people may develop hoarseness, cough, wheezing, shortness of breath, or a harsh breathing sound called stridor. Joint pain and swelling are also common. Some people experience eye inflammation, hearing changes, dizziness, fatigue, or constitutional symptoms such as fever and weight loss during flares.
Is relapsing polychondritis always the same in every person? No. The pattern varies widely. Some people have mainly ear or nose inflammation for long periods, while others develop more serious disease involving the eyes, heart, blood vessels, or airways. The severity can change over time, and symptoms may come and go unpredictably. That variability is one reason the condition is often missed early.
Questions About Diagnosis
How is relapsing polychondritis diagnosed? There is no single blood test or imaging study that confirms the diagnosis on its own. Doctors usually make the diagnosis based on the pattern of symptoms, physical examination, and evidence that multiple cartilage-rich areas have been affected. Inflammatory markers such as erythrocyte sedimentation rate or C-reactive protein may be elevated, but these tests are not specific. The diagnosis is often supported by clinical criteria that look for recurring inflammation in typical sites such as the ears, nose, airway, joints, or eyes.
Why is it sometimes difficult to diagnose? The disease is rare and can resemble more common conditions such as ear infection, sinus disease, arthritis, vasculitis, or asthma. Since symptoms may appear in one area at a time, the link between them may not be obvious at first. Also, cartilage inflammation can improve temporarily, which may delay evaluation. Many people see several specialists before the full pattern becomes clear.
What tests may be used? Doctors may order blood tests to look for inflammation and to rule out related autoimmune diseases. Imaging studies can be important when the airway is involved. CT scans, MRI, or specialized airway studies may show narrowing, collapse, or thickening of cartilage structures. Breathing tests can help assess airway function. If symptoms suggest eye, heart, or kidney involvement, additional testing may be needed. In some cases, a cartilage biopsy is performed, but it is not always necessary and is often reserved for uncertain cases.
Can a biopsy confirm it? A biopsy can show inflammation and cartilage damage, but results are not always definitive because the disease can be patchy and the tissue sample may miss the most active area. For that reason, biopsy is not required in every patient. Experienced clinicians often rely more on the overall clinical picture than on tissue sampling alone.
Which doctors diagnose and manage it? Rheumatologists commonly lead care because the condition is immune-mediated. Depending on symptoms, people may also need evaluation by an ear, nose, and throat specialist, pulmonologist, ophthalmologist, cardiologist, or other specialists. Because the disease can affect several organ systems, coordinated care is often important.
Questions About Treatment
How is relapsing polychondritis treated? Treatment aims to reduce inflammation, relieve symptoms, and prevent permanent damage to cartilage and nearby structures. The choice of therapy depends on severity and the organs involved. Mild disease may be managed with anti-inflammatory medicines, while more serious disease often requires corticosteroids and other immunosuppressive medications. If the airway, eyes, heart, or blood vessels are involved, treatment is usually more aggressive.
Are steroids commonly used? Yes. Corticosteroids such as prednisone are often used to control acute flare-ups because they can quickly suppress inflammation. They may be started at higher doses for severe disease and then tapered as symptoms improve. Because long-term steroid use can cause side effects such as bone loss, high blood sugar, weight gain, infection risk, and mood changes, doctors try to use the lowest effective dose and may add other medications to reduce steroid exposure.
What other medicines may be prescribed? Depending on the case, doctors may use disease-modifying immunosuppressive drugs such as methotrexate, azathioprine, mycophenolate, cyclophosphamide, or biologic therapies in selected patients. These medicines help control ongoing immune activity and may lower the chance of recurrent flares. There is no single best drug for everyone, so treatment is often tailored to the pattern of disease and the patient’s response over time.
Can symptoms be treated without strong immune-suppressing drugs? In some mild cases, nonsteroidal anti-inflammatory drugs may help with pain and swelling, especially if the disease is limited and does not threaten vital structures. However, relapsing polychondritis can progress unpredictably, so patients need close follow-up. If symptoms spread or become more severe, stronger therapy is often necessary.
What happens if the airway is affected? Airway involvement is one of the most serious aspects of the disease because inflammation can weaken cartilage in the trachea and bronchi. This may lead to narrowing or collapse of the airway. Treatment may include urgent anti-inflammatory therapy, close monitoring, and sometimes procedures such as airway stenting or other interventions if the airway becomes unstable. Any worsening breathing symptoms should be evaluated promptly.
Is surgery ever needed? Surgery is not the main treatment for the disease itself, but it may be needed to manage complications. Examples include procedures for severe airway narrowing, heart valve problems, or structural damage to the nose or ears. Surgery is usually considered after inflammation is better controlled, because active inflammation can interfere with healing and outcomes.
Questions About Long-Term Outlook
Is relapsing polychondritis life-threatening? It can be, especially when the airway, heart, or major blood vessels are involved. Many people live for years with the condition, particularly when it is recognized early and treated appropriately. The risk is higher when diagnosis is delayed or when repeated inflammation causes irreversible structural damage. The long-term outlook has improved with earlier recognition and more effective immune-suppressing treatments.
Does it always get worse over time? Not necessarily. Some people have intermittent flares with long periods of relative stability. Others have persistent disease that requires ongoing treatment. The course is highly variable, and the goal of care is to prevent inflammation from causing permanent cartilage destruction or organ damage. Regular monitoring helps identify changes early.
Can it cause permanent changes? Yes. Repeated inflammation can permanently weaken cartilage. This may lead to a saddle-nose deformity, floppy ear cartilage, hearing problems, or airway collapse in severe cases. Early treatment reduces the likelihood of lasting damage, but some structural changes may still occur even when inflammation is controlled later.
What complications should people know about? Potential complications include airway narrowing, hearing loss, balance problems, inflammation of the eyes, heart valve disease, inflammation of blood vessels, and joint damage. Rarely, serious complications can occur if inflammation affects the aorta or other major structures. The risk depends on which tissues are involved and how active the disease is.
Questions About Prevention or Risk
Can relapsing polychondritis be prevented? Because the exact cause is unknown, there is no proven way to prevent it. It is not caused by poor lifestyle choices, and there is no known vaccine or supplement that prevents the disease. The most important strategy is early recognition and treatment to limit damage once symptoms begin.
Are there known risk factors? The condition can occur at any age, but it is most often diagnosed in middle adulthood. Some studies suggest a slight female predominance. It may occur alongside other autoimmune diseases, which can increase suspicion in a person who already has an immune-mediated condition. Still, many patients have no clear risk factor other than the disease itself.
Can lifestyle changes help? Lifestyle changes do not treat the underlying immune process, but they can support overall health. Avoiding smoking is especially important because airway disease can be worsened by lung irritation. Maintaining routine follow-up, taking prescribed medication consistently, and reporting new symptoms early are key steps that help reduce complications. General measures such as staying physically active within one’s limits and protecting bone health during steroid therapy may also be useful.
Less Common Questions
Is relapsing polychondritis contagious? No. It cannot be spread from person to person. It is an inflammatory disease driven by abnormal immune activity, not an infection.
Does it affect only cartilage? Cartilage inflammation is central, but the disease can involve other connective tissues and organs as well. That is why it may affect the eyes, inner ear, heart valves, blood vessels, and respiratory tract. The name highlights cartilage, but the clinical picture can extend beyond it.
Can children get it? Yes, but it is uncommon in children. When it does occur, diagnosis can be especially challenging because symptoms may be mistaken for more common childhood conditions. Management principles are similar, but treatment must be tailored carefully by specialists.
Is there a cure? There is no permanent cure at present. Many patients do well with treatment, and disease activity can sometimes enter remission, meaning symptoms are controlled or absent for a period. However, relapses can still happen, so ongoing follow-up is usually necessary.
Should people seek urgent care for certain symptoms? Yes. New or worsening breathing difficulty, noisy breathing, chest pain, fainting, sudden hearing loss, severe eye pain, or signs of heart or blood vessel involvement need prompt medical attention. These symptoms may signal complications that require urgent evaluation.
Conclusion
Relapsing polychondritis is a rare immune-mediated disease that targets cartilage and sometimes other tissues throughout the body. Its symptoms can range from painful ear or nose inflammation to more serious airway, eye, heart, or blood vessel complications. Because it does not have a single confirmatory test, diagnosis depends on recognizing the pattern of recurrent inflammation. Treatment often involves corticosteroids and other immune-suppressing medicines, with the goal of controlling flares and preventing structural damage. While the condition can be serious, earlier diagnosis and careful long-term management can improve outcomes and reduce complications.